| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Gritstone bio Inc (NASDAQ: GRTS)
GRTS Technical Analysis
5
| As on 9th Jun 2023 GRTS STOCK Price closed @ 2.35 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.99 & Strong Sell for SHORT-TERM with Stoploss of 7.11 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GRTSSTOCK Price
| Open | 2.50 | Change | Price | % |
| High | 2.50 | 1 Day | -0.15 | -6.00 |
| Low | 2.25 | 1 Week | 0.64 | 37.43 |
| Close | 2.35 | 1 Month | -0.07 | -2.89 |
| Volume | 908836 | 1 Year | -11.36 | -82.86 |
| 52 Week High 13.71 | 52 Week Low 1.66 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| GRTS Daily Charts |
GRTS Intraday Charts |
Whats New @ Bazaartrend |
GRTS Free Analysis |
|
|
GRTS Important Levels Intraday
| RESISTANCE | 2.83 |
| RESISTANCE | 2.68 |
| RESISTANCE | 2.58 |
| RESISTANCE | 2.49 |
| SUPPORT | 2.21 |
| SUPPORT | 2.12 |
| SUPPORT | 2.02 |
| SUPPORT | 1.87 |
GRTS Forecast May 2024
| 4th UP Forecast | 7.67 |
| 3rd UP Forecast | 5.96 |
| 2nd UP Forecast | 4.91 |
| 1st UP Forecast | 3.85 |
| 1st DOWN Forecast | 0.85 |
| 2nd DOWN Forecast | -0.21 |
| 3rd DOWN Forecast | -1.26 |
| 4th DOWN Forecast | -2.97 |
GRTS Weekly Forecast
| 4th UP Forecast | 6.09 |
| 3rd UP Forecast | 4.89 |
| 2nd UP Forecast | 4.15 |
| 1st UP Forecast | 3.41 |
| 1st DOWN Forecast | 1.29 |
| 2nd DOWN Forecast | 0.55 |
| 3rd DOWN Forecast | -0.19 |
| 4th DOWN Forecast | -1.39 |
GRTS Forecast2024
| 4th UP Forecast | 26.98 |
| 3rd UP Forecast | 19.08 |
| 2nd UP Forecast | 14.2 |
| 1st UP Forecast | 9.32 |
| 1st DOWN Forecast | -4.62 |
| 2nd DOWN Forecast | -9.5 |
| 3rd DOWN Forecast | -14.38 |
| 4th DOWN Forecast | -22.28 |
Gritstone bio Inc ( NASDAQ USA Symbol : GRTS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GRTS Business Profile
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing tumor-specific cancer immunotherapies to fight various cancer types and infectious diseases. Its lead product candidate is GRANITE, which is in Phase I/II clinical trial for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors, including metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and other mutation-positive tumors. Gritstone Oncology, Inc. has a strategic collaboration with bluebird bio, Inc. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was founded in 2015 and is headquartered in Emeryville, California. Address: 5959 Horton Street, EmeryVille, CA, United States, 94608
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service